Skip to content

DEXAMED

Active
Private limited companyfounded 200719 yrs activeBlauwhuisstraat 26, 8020 Oostkamp, BelgiumKBO/BCE: BE 0886.182.892
Summary

DEXAMED has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €426,358 and a net result of €11,008. Equity remains stable across the filed fiscal years (±1.5% per year). Its solvency ranks better than 80% of 660 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability42▲+15
Solvency100=
Growth32=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30,000 at 30 days acceptable
Liquidity ample (current ratio 2.02 against 2.37 in 2024; short-term debt: 17.5% and cash: 5.5% of total assets), and 24.7% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 32
Relative position
BE, all sectors
reference
Other manufacturing (NACE 32)
about 28% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 19 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
75.3%
Return on assets
1.9%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 23-12-2025, 39 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
39 d early
2024
74 d early
2023
23 d early
2022
48 d early
2021
17 d early
2020
46 d early
2019
18 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 33 days before the deadline; the sector median for financial year 2024 is 2 days before the deadline, and 40% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 23 December (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-06-2026 close28-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 8 January 2007, DEXAMED was incorporated.1 Hilde Focke has served as director of the company since 2026.2 Total assets went from EUR 972,726 in 2019 to EUR 566,313 in 2025.3

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 16-07-2026
  3. 3National Bank, annual accounts 2019 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€426,358▼ 1.1%
2024 · €431,070
Total assets
€566,313▼ 0.5%
2024 · €569,321
Net result
€11,008
2024 · -€4,050
Working capital
€101,047▼ 16.3%
2024 · €120,700
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 32, Other manufacturing, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€21,372▼ 51.2%€54,952▲ 157%-€21,906€244€7,911▲ 3,144%
Net result€13,276within the sector's middle half▼ 40.8%€25,865within the sector's middle half▲ 94.8%-€85,618below the sector's middle half-€4,050below the sector's middle half▲ 95.3%€11,008within the sector's middle half
Equity€496,473above the sector's middle half▲ 2.4%€520,738above the sector's middle half▲ 4.9%€435,120above the sector's middle half▼ 16.4%€431,070above the sector's middle half▼ 0.9%€426,358above the sector's middle half▼ 1.1%
Total assets€606,717above the sector's middle half▼ 3.5%€641,098above the sector's middle half▲ 5.7%€543,109above the sector's middle half▼ 15.3%€569,321above the sector's middle half▲ 4.8%€566,313above the sector's middle half▼ 0.5%
Debt€110,243▼ 23.5%€120,360▲ 9.2%€107,989▼ 10.3%€138,250▲ 28.0%€139,955▲ 1.2%
Working capital€453,514above the sector's middle half▼ 1.0%€340,701above the sector's middle half▼ 24.9%€132,135above the sector's middle half▼ 61.2%€120,700above the sector's middle half▼ 8.7%€101,047within the sector's middle half▼ 16.3%
Solvency81.8%above the sector's middle half▲ 4.7pp81.2%above the sector's middle half▼ 0.6pp80.1%above the sector's middle half▼ 1.1pp75.7%above the sector's middle half▼ 4.4pp75.3%above the sector's middle half▼ 0.4pp
Current ratio19.63above the sector's middle half▲ 8.988.45above the sector's middle half▼ 11.173.92above the sector's middle half▼ 4.532.37within the sector's middle half▼ 1.552.02within the sector's middle half▼ 0.35
Return on assets (ROA)2.2%within the sector's middle half▼ 1.4pp4.0%within the sector's middle half▲ 1.8pp-15.8%below the sector's middle half▼ 19.8pp-0.7%within the sector's middle half▲ 15.1pp1.9%within the sector's middle half▲ 2.7pp
above within below the middle half (P25 to P75) of NACE 32, Other manufacturing, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€100,000-€50,000€0€50,000Operating result 2021: €21,372€21,372Net result 2021: €13,276€13,276Operating result 2022: €54,952€54,952Net result 2022: €25,865€25,865Operating result 2023: -€21,906-€21,906Net result 2023: -€85,618-€85,618Operating result 2024: €244€244Net result 2024: -€4,050-€4,050Operating result 2025: €7,911€7,911Net result 2025: €11,008€11,00820212022202320242025-€100,000-€75,000-€50,000-€25,000€0Operating result 2023: -€21,906-€21,900Net result 2023: -€85,618-€85,600Operating result 2024: €244€244Net result 2024: -€4,050-€4,050Operating result 2025: €7,911€7,910Net result 2025: €11,008€11,000202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 3,144% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €566,313
Fixed assets €366,182 ▲ 1.6%
Current assets €200,131 ▼ 4.1%
Equity and liabilities €566,313
Equity €426,358 ▼ 1.1%
Debt €139,955 ▲ 1.2%
Debt's share of the balance-sheet total rises from 24.3% to 24.7%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€19,227▲
2024 · €7,315
Cash flow
€22,323▲
2024 · €3,021
Debt to equity
0.33▲
2024 · 0.32
ROE
2.6%▲
2024 · -0.9%
Interest coverage
2.48▲
2024 · 1.12
Debt ≤ 1 year
€99,083▲
2024 · €88,095
Debt > 1 year
€36,824▼
2024 · €50,155
Income taxes
€2,992▲
2024 · €460
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 52 lines
Balance sheet Code20242025
Assets
Total assets20/58€569,321€566,313▼
Fixed assets21/28€360,525€366,182▲
Tangible fixed assets22/27€75,613€81,270▲
Land and buildings22€45,847€42,639▼
Plant, machinery and equipment23€8,389€6,555▼
Furniture and vehicles24€20,107€30,806▲
Other tangible fixed assets26€1,270€1,270=
Financial fixed assets28€284,912€284,912=
Current assets29/58€208,795€200,131▼
Amounts receivable within one year40/41€96,808€99,468▲
Trade receivables40€70,973€73,998▲
Other amounts receivable41€25,835€25,470▼
Current investments50/53€100,000€68,268▼
Cash at bank and in hand54/58€10,726€31,074▲
Deferred charges and accrued income490/1€1,261€1,320▲
Equity and liabilities
Total equity and liabilities10/49€569,321€566,313▼
Equity10/15€431,070€426,358▼
Contributions10/11€20,000€20,000=
Reserves13€411,070€406,358▼
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€411,070€406,358▼
Profit (loss) carried forward14-€0
Amounts payable17/49€138,250€139,955▲
Amounts payable after more than one year17€50,155€36,824▼
Financial debts170/4€50,155€36,824▼
Amounts payable within one year42/48€88,095€99,083▲
Current portion of amounts payable after more than one year42€12,597€13,331▲
Trade debts44€6,853€6,910▲
Suppliers440/4€6,853€6,910▲
Taxes, remuneration and social security45€10,663€12,243▲
Taxes450/3€10,663€12,243▲
Other amounts payable47/48€57,982€66,599▲
Accrued charges and deferred income492/3-€4,048
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7,071€11,316▲
Other operating charges640/8€1,319€1,757▲
Gross operating margin9900€8,634€20,983▲
Operating profit (loss)9901€244€7,911▲
Financial income75/76B€2,694€13,831▲
Recurring financial income75€2,694€13,831▲
Financial charges65/66B€6,527€7,742▲
Recurring financial charges65€6,527€7,742▲
Profit (loss) for the period before taxes9903-€3,590€13,999▲
Income taxes67/77€460€2,992▲
Profit (loss) for the period9904-€4,050€11,008▲
Profit (loss) for the period to be appropriated9905-€4,050€11,008▲
Appropriation of the result
Profit (loss) to be appropriated9906-€4,050€11,008▲
Transfer from equity791/2€4,050€15,720▲
Transfer to equity691/2-€11,008
To other reserves6921-€11,008
Profit to be distributed694/7-€15,720
Return on contributions (dividend)694-€15,720

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€31,403€12,631€10,103€7,071€11,316▲ 60.0%
Other operating charges640/8-€2,810€1,190€1,319€1,757▲ 33.2%
Gross operating margin9900€59,008€70,394-€10,613€8,634€20,983▲ 143%
Operating profit (loss)9901€21,372€54,952-€21,906€244€7,911▲ 3,144%
Financial income75/76B-€3,707€864€2,694€13,831▲ 413%
Recurring financial income75€0€3,707€864€2,694€13,831▲ 413%
Financial charges65/66B-€14,965€64,096€6,527€7,742▲ 18.6%
Recurring financial charges65€6,132€14,965€64,096€6,527€7,742▲ 18.6%
Profit (loss) for the period before taxes9903€15,240€43,693-€85,138-€3,590€13,999▲ 490%
Income taxes67/77€1,964€17,829€480€460€2,992▲ 550%
Profit (loss) for the period9904€13,276€25,865-€85,618-€4,050€11,008▲ 372%
Profit (loss) for the period to be appropriated9905€13,276€25,865-€85,618-€4,050€11,008▲ 372%
Line20212022202320242025Change
Assets
Total assets20/58€606,717€641,098€543,109€569,321€566,313▼ 0.5%
Fixed assets21/28€128,853€254,682€365,738€360,525€366,182▲ 1.6%
Tangible fixed assets22/27€91,811€90,928€80,826€75,613€81,270▲ 7.5%
Land and buildings22-€52,263€49,055€45,847€42,639▼ 7.0%
Plant, machinery and equipment23-€9,270€7,901€8,389€6,555▼ 21.9%
Furniture and vehicles24-€28,125€22,600€20,107€30,806▲ 53.2%
Other tangible fixed assets26-€1,270€1,270€1,270€1,270=
Financial fixed assets28€37,042€163,754€284,912€284,912€284,912=
Current assets29/58€477,864€386,415€177,372€208,795€200,131▼ 4.1%
Amounts receivable within one year40/41€42,058€31,222€42,236€96,808€99,468▲ 2.7%
Trade receivables40-€31,218€32,712€70,973€73,998▲ 4.3%
Other amounts receivable41-€4€9,524€25,835€25,470▼ 1.4%
Current investments50/53€200,000€257,003€100,000€100,000€68,268▼ 31.7%
Cash at bank and in hand54/58€227,593€93,327€34,015€10,726€31,074▲ 190%
Deferred charges and accrued income490/1-€4,863€1,121€1,261€1,320▲ 4.7%
Equity and liabilities
Total equity and liabilities10/49€606,717€641,098€543,109€569,321€566,313▼ 0.5%
Equity10/15€496,473€520,738€435,120€431,070€426,358▼ 1.1%
Contributions10/11-€20,000€20,000€20,000€20,000=
Reserves13€476,473€500,738€415,120€411,070€406,358▼ 1.1%
Non-distributable reserves130/1-€2,000€2,000€0--
Reserves not available under the articles1311-€2,000€2,000€0--
Distributable reserves133-€498,738€413,120€411,070€406,358▼ 1.1%
Profit (loss) carried forward14-€0€0-€0-
Amounts payable17/49€110,243€120,360€107,989€138,250€139,955▲ 1.2%
Amounts payable after more than one year17€85,894€74,645€62,752€50,155€36,824▼ 26.6%
Financial debts170/4-€74,645€62,752€50,155€36,824▼ 26.6%
Amounts payable within one year42/48€24,350€45,714€45,237€88,095€99,083▲ 12.5%
Current portion of amounts payable after more than one year42-€11,248€11,893€12,597€13,331▲ 5.8%
Trade debts44€1,318€3,191€3,153€6,853€6,910▲ 0.8%
Suppliers440/4-€3,191€3,153€6,853€6,910▲ 0.8%
Taxes, remuneration and social security45-€20,040€13,249€10,663€12,243▲ 14.8%
Taxes450/3-€20,040€13,249€10,663€12,243▲ 14.8%
Other amounts payable47/48-€11,235€16,942€57,982€66,599▲ 14.9%
Accrued charges and deferred income492/3----€4,048-
Line20212022202320242025Change
Profit (loss) for the period9904€13,276€25,865-€85,618-€4,050€11,008▲ 372%
+ Depreciation and write-downs630€31,403€12,631€10,103€7,071€11,316▲ 60.0%
Operating cash flow (approximation)€44,679€38,496-€75,515€3,021€22,323▲ 639%
Investment in fixed assets (approximation)--€138,461-€121,158-€1,859-€16,973▼ 813%
Change in cash--€134,265-€59,312-€23,289€20,348▲ 187%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
16-07
State Gazette act Appointment: Hilde Focke (director)
Resignation: Xavier Deklerck (director)3 facts ▸
  • General meeting, 08-07-2026
  • Director appointment, Hilde Focke (director)
  • Director resignation, Xavier Deklerck (director)
2025
23-12
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
30-06
Financial Back to profitnet €11,008
Net result €11,008 after 2 loss-making years.
2024
18-11
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
08-01
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial Weakest financial yearnet -€85,618
Net result drops to -€85,618, the lowest in the series; recovery starts the following year.
2022
14-12
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
30-06
Financial Highest result since 2019net €25,865 ▲94.8%
Operating result €54,952, net result €25,865, both a record.
30-06
Financial Equity above €500,000Eq €520,738 ▲4.9%
4 profitable years in a row build equity to €520,738.
14-01
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2020
16-12
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
30-06
Financial Liquidity triplescurrent ratio 10.64
Current ratio from 3.71 to 10.64; short-term debt falls from €89,383 to €47,516.
Show earlier events
18-02
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 18 days late
2019
28-02
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 28 days late
2018
27-02
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 27 days late
2017
13-01
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 3 acts read
About the unread acts

Of the 3 Belgian State Gazette acts we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 director, last change in 2026
Hilde Focke
Director · since 08-07-2026
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
2 of this company's 3 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Oostkamp · 1 establishment unit since 2007
seat establishment The establishment unit on the map
Ground area
3,328 m²
Building footprint
254 m²
Volume, LiDAR
1,518 m³
Parcel 31009D0985/00G002, Flanders · tallest building 10.4 m, ±2 floors. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
Dexamed
Blauwhuisstraat 26, 8020 OostkampNACE 3310206
since 20072.159.486.650
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31009D0985/00G002 Flanders 3,328 m² 1 · 254 m² 10.4 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

2 people since 2026, 1 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Hilde Focke
  • Director, from 08-07-2026 to date
Xavier Deklerck
  • Director, until 08-07-2026
See the board, name and seat on a given date →

Structure & network

Owners and holdings

2 holdings

Owners 0

The accounts to 30-06-2025 list no shareholders, and no other source names one.

Holdings 2

According to the annual accounts to 30-06-2025 of DEXAMED and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Similar companies · same sector, comparable size

Of 1,248 companies in sector 32500 we hold annual accounts for 694. 510 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded08-01-2007
Fiscal year end30-06
Activities, NACEBEL 2025
32500Manufacture of medical and dental instruments and supplies
70200Business and other management consultancy
77225Rental and leasing activities
Contact
Phone 0196/26.06.39Oostkamp
E-invoicing
Reachable via Peppol
Peppol ID 0208:0886182892
Also 9925:BE0886182892
Registered 27-03-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.